Hi all, just at the research stage here into FTT and not sure this has been discussed. Cash burn of about 3M this quarter and with 6M in the back at 30/6 seems like they are running it pretty tight leading into results in December. Would you expect small raise (no doubt at a higher price than 4c) in Nov or do you get the impression they are that confident of raising post results? Also might explain the large swings in the SP? I might also be over estimating the cash burn in Q4 as the trail is ending and the patient numbers decrease?
- Forums
- ASX - By Stock
- DLM
- Ann: CEO presentation to Broker Meets Biotech - Perth
Ann: CEO presentation to Broker Meets Biotech - Perth, page-45
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable